Recently, @Neuralgroover, creator of @VirtualHeadache, explained the significance, clinical data, and patient potential behind CT-132, the first @US_FDA-approved digital therapeutic for #migraine prevention.
Read more on our site now: https://t.co/bC3A4LEK8z